Loading
Old version — revision 1
This is a fixed snapshot of Brain preservation, saved by Import as part of the initial corpus import. It is not edited and it is not updated; the article may have changed since.
Edit summary: Initial import of content/brain-preservation.md — the filesystem corpus, unchanged. Not an edit.
Preserving the structural information in a brain well enough that a future technology could reconstruct its memories, rather than revive the tissue itself.
Brain preservation is the storage of a brain in a state that retains the structural information thought to encode memory and personality, on the assumption that this information — not the living tissue — is what would have to survive for a person to be recoverable. It differs from Cryonics in an important respect: the leading method is chemically irreversible and makes no attempt to keep the brain biologically viable. It is a bet on scanning, not on resuscitation, and it is taken up mainly by people who do not expect Longevity escape velocity to arrive in time for them.
The premise is that a person's memories and character are physically instantiated in the arrangement of their neurons and synapses, together with molecular details such as receptor composition and synaptic strength. If that arrangement can be frozen in place — literally or chemically — then in principle it can later be read out, whatever the state of the tissue.
This shifts the success criterion. Cryonics asks whether damage can be repaired; brain preservation asks whether information has been destroyed. The two lead to different procedures. A method that crosslinks every protein in the brain into an immobile mesh would be catastrophic for revival and excellent for structural preservation, and that is roughly what the field's leading technique does.
The trade being madeAldehyde fixation is the standard preparation for electron microscopy precisely because it locks ultrastructure in place. It also makes the tissue permanently non-living. Brain preservation accepts that trade; classical cryonics does not.
Aldehyde-stabilized cryopreservation (ASC) was published in 2015 by Robert McIntyre and Greg Fahy, whose earlier work produced the low-toxicity vitrification solutions that Cryonics organizations use.1 The procedure perfuses the brain's vasculature with glutaraldehyde, which crosslinks proteins within seconds and halts decay, then introduces a high concentration of a cryoprotectant — ethylene glycol in the published protocol — and cools the brain below its glass transition, around −135 °C, where it can be stored without ice formation or further chemical change.
Fixation solves the problem that limits conventional vitrification. Because the tissue is already stabilized, cryoprotectant can be introduced slowly and at concentrations that would be fatally toxic to living cells, and osmotic damage no longer matters. Fixation also stops the clock immediately, whereas a purely cryogenic protocol must race cooling against ischemia.
The published demonstrations used a rabbit brain and later a whole pig brain, with electron micrographs sampled across the specimen showing intact cell membranes, synapses and synaptic vesicles. Verification was the point: earlier preservation claims had rested on gross appearance rather than on ultrastructure at synaptic resolution.
The prize's design mattered more than its money. By fixing the evaluation criterion in advance — uniform preservation of synaptic ultrastructure across an entire brain, judged by independent electron microscopists — it forced a field that had traded in assertion into producing checkable images. It also, by its own terms, said nothing about whether a preserved brain could ever be read.
The argument that structural preservation suffices runs through Connectomics. If memory is stored in the pattern and strength of synaptic connections, then a preserved connectome plus enough molecular annotation is the person in storage, and the remaining work is scanning and simulation — the pipeline described in the Whole brain emulation roadmap by Anders Sandberg and Nick Bostrom.2 Nothing in the method requires the cell-by-cell repair machinery that biological revival scenarios depend on, which is the main reason its advocates consider it the more tractable bet.
The objections are substantial and not resolved.
A wiring diagram may not be enough. The complete connectome of C. elegans has been available since 1986, and its 302 neurons still do not yield a predictive model of the animal's behavior.3 Connectivity omits synaptic weights, neuromodulatory tone, receptor subtypes, gene expression state, and the extrasynaptic signaling that shapes circuit function.
Fixation may destroy what matters. Glutaraldehyde preserves gross ultrastructure but alters protein conformation and does not preserve small molecules, ion gradients, or short-lived phosphorylation states. If any of those carry information relevant to identity, ASC loses it and electron microscopy would not reveal the loss.
Perfusion is uneven in real cases. The demonstrations used healthy animals perfused under controlled conditions. A human brain after cardiac arrest has collapsed capillaries and swollen tissue, and fixative may not reach everywhere.
The success test is unspecified. Even a perfect reconstruction would raise the question of how anyone would know it worked. Behavioral resemblance underdetermines the answer, as the debates over Machine consciousness and the Neural correlates of consciousness make clear, and the preserved person is not available to check against.
Nothing has been read back. No preserved brain of any species has been scanned and shown to yield a functioning model. Until something is, the criterion "connectome preserved" is a proxy for success whose relationship to actual success is unmeasured. This is the same gap that separates a Memory prosthesis that can write a hippocampal code from one that can read an existing memory.
Because good perfusion requires intact circulation, the ideal application of ASC is to a patient who is anesthetized and alive at the moment fixation begins. That makes the procedure a cause of death rather than a response to one, and places it squarely inside the assisted-dying debate rather than beside it. Advocates ground the claim in Morphological freedom and the right to dispose of one's own body; opponents note that no other elective procedure is both irreversible and immediately lethal, and that consent to it is being sought on the strength of a technology nobody can demonstrate.
The startup Nectome ran into this directly. Founded by McIntyre to commercialize ASC, it attracted attention in 2018 for a service described in press coverage as "100 percent fatal", accepted refundable deposits from a waiting list, and lost its research subcontract with MIT shortly afterward.4 The scientific objection raised at the time was not that the preservation failed but that selling it implied a claim about future revival that nobody could support.
A smaller practice has continued. Some organizations offer chemical fixation with storage at higher temperatures, which is far cheaper than liquid-nitrogen maintenance and may be adequate if the goal is structure rather than viability. A few well-funded startups, including one founded by the longevity investor Laura Deming, have taken the opposite tack and are pursuing genuinely reversible brain cryopreservation, which if achieved would make the fixation trade unnecessary.
What the prize did and did not showThe Brain Preservation Prize established that a large mammalian brain can be preserved with synapses visibly intact throughout. It did not establish that memories survive, that the preserved state is sufficient for reconstruction, or that any scanning technology capable of reading a whole human brain is achievable.
Brain preservation occupies an unusual position: its central technical claim is verifiable and largely verified, while its central practical claim is not testable at all with present knowledge. The bottleneck has moved to the read-out side, where progress depends on the throughput of volume electron microscopy and on whether models built from decoded structure can reproduce function.
The field's honest position is that it preserves an option rather than delivering a result, and that the option's value depends on premises — Substrate independence, the sufficiency of structure, the eventual existence of the scanning pipeline — that are argued rather than demonstrated. Whether preserving that option is worth doing, given that it must be exercised at the cost of a life that would otherwise have ended slightly later, is a question the technical results cannot settle. It is the same question Mind uploading raises, arriving decades earlier because the preservation half is already available.
paperMcIntyre, R.L. and Fahy, G.M. "Aldehyde-stabilized cryopreservation." Cryobiology, 2015.↩Demonstrated on rabbit brains; the verification is electron microscopy of preserved structure, which cannot show whether stored information survived.
reportSandberg, A. and Bostrom, N. Whole Brain Emulation: A Roadmap. Future of Humanity Institute, University of Oxford, 2008. ↩
paperWhite, J.G., Southgate, E., Thomson, J.N. and Brenner, S. "The structure of the nervous system of the nematode Caenorhabditis elegans." Philosophical Transactions of the Royal Society B, 1986. ↩
newsRegalado, A. "A startup is pitching a mind-uploading service that is '100 percent fatal'." MIT Technology Review, 2018.↩Reporting on a startup's proposed service and the reaction to it; it describes a business plan, not a scientific result.